Literature DB >> 16194705

Lessons learned in the surgical management of renal cell carcinoma.

Shomik Sengupta1, Horst Zincke.   

Abstract

Surgical excision, the mainstay of management of renal cell carcinoma (RCC), has evolved significantly over the last 4 decades. Radiological imaging is crucial to the diagnosis and staging of RCC, and technological advances have facilitated more precise preoperative assessment. Additionally, wider use of cross-sectional imaging modalities has led to increasing incidental diagnosis of small, early-stage RCC. Nephron-sparing surgery (NSS), originally developed to treat RCC arising in a solitary functioning kidney, has been demonstrated to be a safe and effective alternative to radical nephrectomy. NSS is now also applicable to tumors of suitable size and anatomy in patients with a normal contralateral kidney, thus facilitating preservation of renal function and management of metachronous contralateral pathology. Laparoscopic and percutaneous approaches have developed over the last decade, thus providing minimally invasive modalities, with shortened convalescence and improved cosmesis. Advanced RCC, involving venous extension or nodal spread, is increasingly amenable to surgical management, although appropriate patient selection is crucial. Furthermore, surgical excision of the primary lesion appears to be an integral part of systemic therapy for metastatic RCC.

Entities:  

Mesh:

Year:  2005        PMID: 16194705     DOI: 10.1016/j.urology.2005.06.004

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

Review 1.  Imaging of advanced renal cell carcinoma.

Authors:  Ullrich G Mueller-Lisse; Ulrike L Mueller-Lisse
Journal:  World J Urol       Date:  2010-05-11       Impact factor: 4.226

Review 2.  Direct tissue analysis by matrix-assisted laser desorption ionization mass spectrometry: application to kidney biology.

Authors:  Kristen D Herring; Stacey R Oppenheimer; Richard M Caprioli
Journal:  Semin Nephrol       Date:  2007-11       Impact factor: 5.299

3.  Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.

Authors:  Stacey R Oppenheimer; Deming Mi; Melinda E Sanders; Richard M Caprioli
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

4.  Identification of the primary tumour with the help of diffusion-weighted MRI in a patient with autosomal dominant polycystic kidney disease and metastatic renal cell carcinoma.

Authors:  M Zeile; D Andreou; A Poellinger; P U Tunn; O Dudeck
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

Review 5.  Staging of renal cell carcinoma.

Authors:  Ullrich G Mueller-Lisse; Ulrike L Mueller-Lisse; Thomas Meindl; Eva Coppenrath; Christoph Degenhart; Anno Graser; Michael Scherr; Maximilian F Reiser
Journal:  Eur Radiol       Date:  2007-02-22       Impact factor: 5.315

6.  Economic evaluation of first-line treatments for metastatic renal cell carcinoma: a cost-effectiveness analysis in a health resource-limited setting.

Authors:  Bin Wu; Baijun Dong; Yuejuan Xu; Qiang Zhang; Jinfang Shen; Huafeng Chen; Wei Xue
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.